170 related articles for article (PubMed ID: 38535306)
1. Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and Aging.
Mavrogonatou E; Kletsas D
Metabolites; 2024 Feb; 14(3):. PubMed ID: 38535306
[TBL] [Abstract][Full Text] [Related]
2. Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration.
Wu Y; Shen S; Shi Y; Tian N; Zhou Y; Zhang X
Front Bioeng Biotechnol; 2022; 10():823945. PubMed ID: 35309994
[TBL] [Abstract][Full Text] [Related]
3. Senotherapeutic drugs for human intervertebral disc degeneration and low back pain.
Cherif H; Bisson DG; Mannarino M; Rabau O; Ouellet JA; Haglund L
Elife; 2020 Aug; 9():. PubMed ID: 32821059
[TBL] [Abstract][Full Text] [Related]
4. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and therapeutic strategies for senescence-associated secretory phenotype in the intervertebral disc degeneration microenvironment.
Liu Y; Dou Y; Sun X; Yang Q
J Orthop Translat; 2024 Mar; 45():56-65. PubMed ID: 38495743
[TBL] [Abstract][Full Text] [Related]
6. p16
Novais EJ; Diekman BO; Shapiro IM; Risbud MV
Matrix Biol; 2019 Sep; 82():54-70. PubMed ID: 30811968
[TBL] [Abstract][Full Text] [Related]
7. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 induced senescence in intervertebral disc cells of patients with back pain can be attenuated by o-vanillin.
Mannarino M; Cherif H; Li L; Sheng K; Rabau O; Jarzem P; Weber MH; Ouellet JA; Haglund L
Arthritis Res Ther; 2021 Apr; 23(1):117. PubMed ID: 33863359
[TBL] [Abstract][Full Text] [Related]
9. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
Wong PF; Dharmani M; Ramasamy TS
Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
[TBL] [Abstract][Full Text] [Related]
10. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
Nehlin JO
Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
[TBL] [Abstract][Full Text] [Related]
11. p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle.
Che H; Li J; Li Y; Ma C; Liu H; Qin J; Dong J; Zhang Z; Xian CJ; Miao D; Wang L; Ren Y
Elife; 2020 Mar; 9():. PubMed ID: 32125276
[TBL] [Abstract][Full Text] [Related]
12. Cellular Senescence in Intervertebral Disc Aging and Degeneration: Molecular Mechanisms and Potential Therapeutic Opportunities.
Silwal P; Nguyen-Thai AM; Mohammad HA; Wang Y; Robbins PD; Lee JY; Vo NV
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189433
[TBL] [Abstract][Full Text] [Related]
13. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
[TBL] [Abstract][Full Text] [Related]
14. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
[TBL] [Abstract][Full Text] [Related]
15. Local Delivery of Senolytic Drug Inhibits Intervertebral Disc Degeneration and Restores Intervertebral Disc Structure.
Lim S; An SB; Jung M; Joshi HP; Kumar H; Kim C; Song SY; Lee JR; Kang M; Han I; Kim BS
Adv Healthc Mater; 2022 Jan; 11(2):e2101483. PubMed ID: 34699690
[TBL] [Abstract][Full Text] [Related]
16. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted senotherapeutic interventions.
Atayik MC; Çakatay U
Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
[TBL] [Abstract][Full Text] [Related]
18. Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis.
Shao Z; Wang B; Shi Y; Xie C; Huang C; Chen B; Zhang H; Zeng G; Liang H; Wu Y; Zhou Y; Tian N; Wu A; Gao W; Wang X; Zhang X
Osteoarthritis Cartilage; 2021 Mar; 29(3):413-422. PubMed ID: 33242601
[TBL] [Abstract][Full Text] [Related]
19. PGC1α-Inducing Senomorphic Nanotherapeutics Functionalized with NKG2D-Overexpressing Cell Membranes for Intervertebral Disc Degeneration.
Liu S; Li K; He Y; Chen S; Yang W; Chen X; Feng S; Xiong L; Peng Y; Shao Z
Adv Sci (Weinh); 2024 Mar; ():e2400749. PubMed ID: 38554394
[TBL] [Abstract][Full Text] [Related]
20. Elimination of Senescent Cells by Senolytics Facilitates Bony Endplate Microvessel Formation and Mitigates Disc Degeneration in Aged Mice.
Chen B; Zhu R; Hu H; Zhan M; Wang T; Huang F; Wei F; Chai Y; Ling Z; Zou X
Front Cell Dev Biol; 2022; 10():853688. PubMed ID: 35874831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
